怡亞通(002183.SZ):上海新世紀擬獲增加投資
格隆匯1月20日丨怡亞通(002183.SZ)公佈,因業務發展需要,公司控股子公司上海新世紀日用化學品有限公司(“上海新世紀”)的法人股東上海深怡供應鏈管理有限公司(“上海深怡”)向其增加投資人民幣3071.6109萬元,上海新世紀的自然人股東金純鳴向其增加投資人民幣1379.9991萬元。上海新世紀目前的註冊資本為人民幣3548.39萬元,此次增資完成後,上海新世紀的註冊資本將增至人民幣8000萬元,公司佔其註冊資本的69%。
通過前期投入,公司已經在上海市及華東區域搭建起業務運作的平台,業務規模快速擴張,分銷能力受到越來越多客户和供應商的認可。而隨着中國經濟實力不斷上升,消費市場日趨擴大,此次增資完成後,有利於進一步提高上海新世紀的運作效率和服務能力,擴大業務規模,同時對進一步增強公司整體競爭力,實現公司效益最大化有着積極促進作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.